The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
Davies
S P
SP
Department of Medicine, Charing Cross and Westminster Medical School, London, England.
Brown
E A
EA
Woodrow
D F
DF
Phillips
M E
ME
Gower
P E
PE
Mee
A D
AD
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004351:Drug Resistance; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D013256:Steroids; D008775:Methylprednisolone